Revisiting the role of interleukin-8 in chronic lymphocytic leukemia

The proliferation and survival of malignant B cells in chronic lymphocytic leukemia (CLL) depend on signals from the microenvironment in lymphoid tissues. Among a plethora of soluble factors, IL-8 has been considered one of the most relevant to support CLL B cell progression in an autocrine fashion,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Risnik, D., Podaza, E., Almejún, M.B., Colado, A., Elías, E.E., Bezares, R.F., Fernández-Grecco, H., Cranco, S., Sánchez-Ávalos, J.C., Borge, M., Gamberale, R., Giordano, M.
Formato:	JOUR
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_20452322_v7_n1_p_Risnik
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Revisiting the role of interleukin-8 in chronic lymphocytic leukemia
Publicado: (2017)

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells
por: Almejún, M.B., et al.

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
por: Colado, A., et al.

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells
por: Almejún, María Belén, et al.
Publicado: (2017)

Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
por: Elías, E.E., et al.

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
por: Almejún, María Belén, et al.
Publicado: (2017)

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells
por: Rodrigues, J.M., et al.
Publicado: (2006)

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells
por: Rodrigues, J.M., et al.

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells
por: Rodrigues, J.M., et al.
Publicado: (2006)

Zinc Oxide Nanoparticles and Photodynamic Therapy for the Treatment of B-chronic Lymphocytic Leukemia
por: Loydover Peña Luengas, Sandra, et al.
Publicado: (2015)

Progression of Chronic Lymphocytic Leukemia into Hodgkin Lymphoma during Ibrutinib treatment. Case Report
por: Heller , VB, et al.
Publicado: (2019)

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells
por: Elías, Fernanda
Publicado: (2006)

Venetoclax in combination with obinutuzumab in first line chronic lymphocytic leukemia in Argentina: A cost-effectiveness analysis
por: Kanevsky, Diego, et al.
Publicado: (2022)

Protothecosis in a patient with T cell lymphocytic leukemia
por: Fernández, Mariana Soledad, et al.
Publicado: (2021)

Apoptosis induced by <i>Magnolia Grandiora</i> extract in chlorambucil-resistant B-chronic lymphocytic leukemia cells
por: Marín, Gustavo Horacio, et al.
Publicado: (2010)

B-Chronic Lymphocytic Leukemia Autophagyc Cell Death by the Use of Manganese Doped Zinc Oxide Nanoparticles and Photo-Dynamic Therapy
por: Peña Luengas, Sandra, et al.
Publicado: (2015)

Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia
por: Schillaci, R., et al.

Leukaemia cutis: clinical manifestation of chronic lymphocytic leukaemia relapse.
por: Sureda, Nadia C, et al.
Publicado: (2019)

Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
Publicado: (2018)

Leukemia cutis /
por: Bluefarb, Samuel M.
Publicado: (1960)

Leukemia [Leukemia] NLMUID: 8704895

Single nucleotide polymorphism in PTEN-Long gene : a risk factor in chronic myeloid leukemia
por: Ferri, Cristian Alberto, et al.
Publicado: (2019)

Leukemia /
Publicado: (1964)

Insulin effect on interleukin 1 (IL-1) and interleukin 6 (IL-6) production by lipopolysaccharide-stimulated human monocytes
por: Schillaci, R., et al.

Leukemia official journal of the Leukemia Society of America, Leukemia Research Fund, U.K.

Antagonistic effect of insulin and cortisol on stimulated lymphocytes
por: Castillo, M.B., et al.

Leukemia-lymphoma /
Publicado: (1970)

Leukemia & lymphoma
Publicado: (1989)

The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib
por: Bestach, Yesica, et al.
Publicado: (2019)

Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia
Publicado: (2005)

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
por: Ilarregui, J.M., et al.

Interleukin-1β enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures
por: Sauer, J., et al.

Effect of histamine on human lymphocyte aggregation
por: Maugeri, N., et al.

Altered interferon-γ expression in lymphocytes as a potential peripheral marker of chronic stress-induced cognitive deficit
por: Palumbo, María Laura, et al.
Publicado: (2019)

Somatic Hypermutation Defects in Common Variable Immune Deficiency
por: Almejun, M.B., et al.

Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes
por: Chasseing, N.A., et al.

Lymphocyte subsets and cytokines in adenoviral infection in children
por: Mistchenko, A.S., et al.

Polypeptide Synthesis in Toluene‐Treated Lymphocytes
por: BURRONE, O.R.

The scar mechanism revisited
por: Borondo, F., et al.

Interleukin-1β enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures
Publicado: (1998)